However, the CYP2A6 enzyme can act directly via metabolically activating procarcinogenic tobacco-specific nitrosamines NNN and NNK via α-hydroxylation [10,11] suggesting that slower activation may also lower lung cancer risk. Here, CYP2A6 is linked to lung cancer.